ICUI · Icu Medical Inc/De

$182.98 -0.13 (-0.07%) At close · Aug 14

Customer concentration — top customer 19% of revenue

One customer — 19% of revenue (the six months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2026)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 19% of revenue (the three months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

One customer — 18% of revenue (the six months ended June 30, 2025)

“For the three and six months ended June 30, 2026, our consolidated worldwide net sales to a single distributor were 19%, and 19%, respectively, and for the three and six months ended June 30, 2025, were 19% and 18%.”

View the 10-Q filed Aug 6, 2026

Market Cap

$4.58B

25.01M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$775,000	—	$4,500,023	—	$1,162,500	$14,519	$6,452,042
Christian Voigtlander	Chief Operating Officer	$500,000	—	$3,000,110	—	$450,000	—	$3,950,110
Brian Bonnell	Chief Financial Officer	$475,000	—	$3,000,110	—	$427,500	—	$3,902,610
Virginia Sanzone	Corporate Vice President, General Counsel	$430,000	—	$2,000,073	—	$387,000	—	$2,817,073
Daniel Woolson	Corporate Vice President, General Manager - Infusion Systems	$395,192	—	$1,350,135	—	$360,000	$11,500	$2,116,827

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$775,000	—	$4,500,004	—	$1,162,500	$17,250	$6,454,754
Christian Voigtlander	Chief Operating Officer	$500,000	$75,000	$3,000,038	—	$450,000	$17,250	$4,042,288
Brian Bonnell	Chief Financial Officer	$475,000	$71,250	$3,000,038	—	$427,500	$17,250	$3,991,038
Virginia Sanzone	Corporate Vice President, General Counsel	$430,000	$64,500	$1,999,990	—	$387,000	$17,250	$2,898,740
Daniel Woolson	Corporate Vice President, General Manager - Infusion Systems	$375,000	—	$1,350,190	—	$326,250	$17,250	$2,068,690

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$775,000	—	$5,554,475	—	$465,000	$16,500	$6,810,975
Christian Voigtlander	Chief Operating Officer	$500,000	—	$3,702,920	—	$180,000	$16,500	$4,399,420
Brian Bonnell	Chief Financial Officer	$475,000	$23,085	$3,702,920	—	$171,000	$16,500	$4,388,505
Virginia Sanzone	Corporate Vice President, General Counsel	$430,000	$20,898	$1,851,555	—	$154,800	$16,500	$2,473,753
Daniel Woolson	Corporate Vice President, General Manager - Infusion Systems	$375,000	$17,550	$1,666,475	—	$135,000	$16,500	$2,210,525
Dan Woolson	Corporate Vice President, General Manager - Infusion Systems	$375,000	$17,550	$1,666,475	—	$135,000	$16,500	$2,210,525

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$755,769	$387,500	$4,500,075	—	—	$13,725	$5,657,069
Christian Voigtlander	Chief Operating Officer	$487,692	$150,000	$3,000,206	—	—	$13,725	$3,651,623
Brian Bonnell	Chief Financial Officer	$462,692	$142,500	$3,000,206	—	—	$13,725	$3,619,123
Virginia Sanzone	Corporate Vice President, General Counsel	$410,000	$129,000	$1,500,102	—	—	$13,725	$2,052,827
Dan Woolson	Corporate Vice President, General Manager - Infusion Systems	$363,462	$112,500	$1,350,233	—	—	$13,725	$1,839,920
Daniel Woolson	Corporate Vice President, General Manager - Infusion Systems	$363,462	$112,500	$1,350,233	—	—	$13,725	$1,839,920

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$650,000	—	$3,757,858	—	$650,000	$13,500	$5,071,358
Christian Voigtlander	Chief Operating Officer	$420,000	—	$3,288,295	—	$252,000	$13,500	$3,973,795
Brian Bonnell	Chief Financial Officer	$395,000	—	$3,288,295	—	$237,000	$13,500	$3,933,795
Virginia Sanzone	Corporate Vice President, General Counsel	$300,000	$30,000	$1,350,107	—	$180,000	$13,500	$1,873,607
Dan Woolson	Corporate Vice President, General Manager - Infusion Systems	$300,000	—	$1,200,183	—	$180,000	$13,500	$1,693,683

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$650,000	$84,500	$2,000,174	—	$565,500	$12,825	$3,312,999
Christian Voigtlander	Chief Operating Officer	$420,000	$32,760	$1,750,176	—	$219,240	$12,825	$2,435,001
Brian Bonnell	Chief Financial Officer	$395,000	$30,810	$1,750,176	—	$206,190	$12,825	$2,395,001
Virginia Sanzone	Corporate Vice President, General Counsel	$300,000	$23,400	$900,106	—	$156,600	$12,825	$1,392,931
Dan Woolson	Corporate Vice President, General Manager - Infusion Systems	$300,000	$23,400	$800,032	—	$156,600	$12,825	$1,292,857
Scott Lamb	Former Chief Financial Officer and Treasurer	$69,513	—	—	—	—	$78,760	$148,273

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$650,000	$162,500	$2,000,402	—	—	$12,375	$2,825,277
Christian Voigtlander	Chief Operating Officer	$420,000	$63,000	$2,000,402	—	—	$12,375	$2,495,777
Dan Woolson	Corporate Vice President, General Manager - Infusion Systems	$300,000	$90,000	$1,000,201	—	—	$12,375	$1,402,576
Virginia Sanzone	Corporate Vice President, General Counsel	$300,000	$90,000	$1,000,201	—	—	$12,375	$1,402,576
Scott Lamb	Former Chief Financial Officer and Treasurer	$395,150	$118,545	$600,213	—	—	$12,375	$1,126,283
Scott E. Lamb	Former Chief Financial Officer and Treasurer	$395,150	$118,545	$600,213	—	—	$12,375	$1,126,283

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$650,000	—	$4,000,033	—	$1,300,000	$12,375	$5,962,408
Christian Voigtlander	Chief Operating Officer	$420,000	—	$1,750,247	—	$554,000	$12,375	$2,736,622
Scott Lamb	Former Chief Financial Officer and Treasurer	$395,150	—	$750,177	—	$474,180	$12,375	$1,631,882
Scott E. Lamb	Former Chief Financial Officer and Treasurer	$395,150	—	$750,177	—	$474,180	$12,375	$1,631,882
Virginia Sanzone	Corporate Vice President, General Counsel	$300,000	—	$750,177	—	$410,000	$12,375	$1,472,552

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Vivek Jain	Chairman of the Board and Chief Executive Officer	$650,000	—	$1,850,192	—	$1,300,000	$18,131	$3,818,323
Scott E. Lamb	Former Chief Financial Officer and Treasurer	$395,150	—	$550,292	—	$474,179	$9,450	$1,429,071

Executive changes

Person	Role	Change	Effective	Filed
Daniel Woolson	President	Appointed	2024-09-30	2024-10-02
William Seeger	board of directors of ICU Medical, Inc. and a member of the Audit and Compliance Committee of the Company Board	Resigned	2024-02-28	2024-02-29
William Seeger	director	Appointed	2023-05-17	2023-05-22
Laurie Hernandez	director	Appointed	2023-05-17	2023-05-22
Kolleen T. Kennedy	director	Appointed	2023-05-17	2023-05-22
David F. Hoffmeister	director	Appointed	2023-05-17	2023-05-22
Donald M. Abbey	director	Appointed	2023-05-17	2023-05-22
Elisha W. Finney	director	Appointed	2023-05-17	2023-05-22
David C. Greenberg	director	Appointed	2023-05-17	2023-05-22
George A. Lopez, M.D.	director	Appointed	2023-05-17	2023-05-22
Vivek Jain	director	Appointed	2023-05-17	2023-05-22

Key facts CIK 883984 CUSIP 44930G107 13F (30d) 263 filings 262 filers Visit website Investor relations